Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun A long-acting beta-adrenoceptor agonist drug (
LABA ) indicated for the treatment ofchronic obstructive pulmonary disease .
Etymologies
from Wiktionary, Creative Commons Attribution/Share-Alike License
Support
Help support Wordnik (and make this page ad-free) by adopting the word arformoterol.
Examples
-
Goodman believes that investors will increasingly return to Sepracor as its Lunesta sleep-aid continues its ramp in the face of new product launches, Xopenex franchise continues to grow, and arformoterol is approved by year-end 2006 or early 2007.
Sepracor Shareholders Can Rest Easy After 'Excellent' Q4 2006
-
Approval for respiratory drug arformoterol could spark additional gains, the analyst added.
-
"We still believe that Sepracor is a good new product story with two products (Lunesta and Xopenex MDI) early in their life cycles and another product (arformoterol) expected to launch in 2007," the analyst added.
-
According to investigators, Medicare paid for 7 million units of the drug arformoterol, even though the manufacturer and the three largest wholesalers sold only 750,000 units in the area in 2008 and the first half of 2009.
-
The spike in arformoterol only came after authorities tried to crack down on another inhaler drug, and illustrates a constant problem plaguing investigators.
-
Fraudulent providers quickly realized they couldn't get as much money for that drug and began billing Medicare for arformoterol at rates exceeding the amount of drugs available.
-
In fact, the high-dose arformoterol group showed somewhat greater reductions in rescue and supplemental medication use at six months than during the first few weeks of treatment.
MedPageToday.com - medical news plus CME for physicians 2008
-
Steven Brown, M.D., a pulmonologist in Glendale, Wis., called the findings reassuring, especially in light of the black-box warning on arformoterol and all other products containing long-acting beta agonists.
MedPageToday.com - medical news plus CME for physicians 2008
-
The values for arformoterol after six months were 0.24 L for the higher dose and 0.20 L for the lower dose, slightly lower than at the trial's start.
MedPageToday.com - medical news plus CME for physicians 2008
-
BROVANA® brand arformoterol tartrate Inhalation Solution, OMNARIS ™ brand ciclesonide Nasal Spray and
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.